Sinovac Biotech, Ltd.
SVA
Market Cap$464.94M
Close$
$15.63
141.6% upside
Current Fair Value
141.6% upsideUndervalued by 141.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $464.94 Million |
|---|---|
| Enterprise Value | $-530,519,271.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.06 |
| Beta | 0 |
| Outstanding Shares | 99,603,965 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.45 |
|---|---|
| PEG | 9.42 |
| Price to Sales | 0.34 |
| Price to Book Ratio | 0.05 |
| Enterprise Value to Revenue | -0.27 |
| Enterprise Value to EBIT | 0.52 |
| Enterprise Value to Net Income | -39 |
| Total Debt to Enterprise | -0.53 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Sinovac Biotech, Ltd.
CEO: Weidong Yin